Costs and cost-effectiveness of periviable care

Aaron Caughey, David J. Burchfield

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

With increasing concerns regarding rapidly expanding healthcare costs, cost-effectiveness analysis allows assessment of whether marginal gains from new technology are worth the increased costs. Particular methodologic issues related to cost and cost-effectiveness analysis in the area of neonatal and periviable care include how costs are estimated, such as the use of charges and whether long-term costs are included; the challenges of measuring utilities; and whether to use a maternal, neonatal, or dual perspective in such analyses. A number of studies over the past three decades have examined the costs and the cost-effectiveness of neonatal and periviable care. Broadly, while neonatal care is costly, it is also cost effective as it produces both life-years and quality-adjusted life-years (QALYs). However, as the gestational age of the neonate decreases, the costs increase and the cost-effectiveness threshold is harder to achieve. In the periviable range of gestational age (22-24 weeks of gestation), whether the care is cost effective is questionable and is dependent on the perspective. Understanding the methodology and salient issues of cost-effectiveness analysis is critical for researchers, editors, and clinicians to accurately interpret results of the growing body of cost-effectiveness studies related to the care of periviable pregnancies and neonates.

Original languageEnglish (US)
Pages (from-to)56-62
Number of pages7
JournalSeminars in Perinatology
Volume38
Issue number1
DOIs
StatePublished - Feb 2014

Fingerprint

Cost-Benefit Analysis
Costs and Cost Analysis
Gestational Age
Pregnancy
Quality-Adjusted Life Years
Health Care Costs
Mothers
Quality of Life
Research Personnel
Technology

Keywords

  • Cost-benefit analysis
  • Cost-effectiveness analysis
  • Down syndrome
  • Economics
  • Prenatal diagnosis-economics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Costs and cost-effectiveness of periviable care. / Caughey, Aaron; Burchfield, David J.

In: Seminars in Perinatology, Vol. 38, No. 1, 02.2014, p. 56-62.

Research output: Contribution to journalArticle

Caughey, Aaron ; Burchfield, David J. / Costs and cost-effectiveness of periviable care. In: Seminars in Perinatology. 2014 ; Vol. 38, No. 1. pp. 56-62.
@article{435d4268bcbc4f0592e80925074d2a72,
title = "Costs and cost-effectiveness of periviable care",
abstract = "With increasing concerns regarding rapidly expanding healthcare costs, cost-effectiveness analysis allows assessment of whether marginal gains from new technology are worth the increased costs. Particular methodologic issues related to cost and cost-effectiveness analysis in the area of neonatal and periviable care include how costs are estimated, such as the use of charges and whether long-term costs are included; the challenges of measuring utilities; and whether to use a maternal, neonatal, or dual perspective in such analyses. A number of studies over the past three decades have examined the costs and the cost-effectiveness of neonatal and periviable care. Broadly, while neonatal care is costly, it is also cost effective as it produces both life-years and quality-adjusted life-years (QALYs). However, as the gestational age of the neonate decreases, the costs increase and the cost-effectiveness threshold is harder to achieve. In the periviable range of gestational age (22-24 weeks of gestation), whether the care is cost effective is questionable and is dependent on the perspective. Understanding the methodology and salient issues of cost-effectiveness analysis is critical for researchers, editors, and clinicians to accurately interpret results of the growing body of cost-effectiveness studies related to the care of periviable pregnancies and neonates.",
keywords = "Cost-benefit analysis, Cost-effectiveness analysis, Down syndrome, Economics, Prenatal diagnosis-economics",
author = "Aaron Caughey and Burchfield, {David J.}",
year = "2014",
month = "2",
doi = "10.1053/j.semperi.2013.07.010",
language = "English (US)",
volume = "38",
pages = "56--62",
journal = "Seminars in Perinatology",
issn = "0146-0005",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Costs and cost-effectiveness of periviable care

AU - Caughey, Aaron

AU - Burchfield, David J.

PY - 2014/2

Y1 - 2014/2

N2 - With increasing concerns regarding rapidly expanding healthcare costs, cost-effectiveness analysis allows assessment of whether marginal gains from new technology are worth the increased costs. Particular methodologic issues related to cost and cost-effectiveness analysis in the area of neonatal and periviable care include how costs are estimated, such as the use of charges and whether long-term costs are included; the challenges of measuring utilities; and whether to use a maternal, neonatal, or dual perspective in such analyses. A number of studies over the past three decades have examined the costs and the cost-effectiveness of neonatal and periviable care. Broadly, while neonatal care is costly, it is also cost effective as it produces both life-years and quality-adjusted life-years (QALYs). However, as the gestational age of the neonate decreases, the costs increase and the cost-effectiveness threshold is harder to achieve. In the periviable range of gestational age (22-24 weeks of gestation), whether the care is cost effective is questionable and is dependent on the perspective. Understanding the methodology and salient issues of cost-effectiveness analysis is critical for researchers, editors, and clinicians to accurately interpret results of the growing body of cost-effectiveness studies related to the care of periviable pregnancies and neonates.

AB - With increasing concerns regarding rapidly expanding healthcare costs, cost-effectiveness analysis allows assessment of whether marginal gains from new technology are worth the increased costs. Particular methodologic issues related to cost and cost-effectiveness analysis in the area of neonatal and periviable care include how costs are estimated, such as the use of charges and whether long-term costs are included; the challenges of measuring utilities; and whether to use a maternal, neonatal, or dual perspective in such analyses. A number of studies over the past three decades have examined the costs and the cost-effectiveness of neonatal and periviable care. Broadly, while neonatal care is costly, it is also cost effective as it produces both life-years and quality-adjusted life-years (QALYs). However, as the gestational age of the neonate decreases, the costs increase and the cost-effectiveness threshold is harder to achieve. In the periviable range of gestational age (22-24 weeks of gestation), whether the care is cost effective is questionable and is dependent on the perspective. Understanding the methodology and salient issues of cost-effectiveness analysis is critical for researchers, editors, and clinicians to accurately interpret results of the growing body of cost-effectiveness studies related to the care of periviable pregnancies and neonates.

KW - Cost-benefit analysis

KW - Cost-effectiveness analysis

KW - Down syndrome

KW - Economics

KW - Prenatal diagnosis-economics

UR - http://www.scopus.com/inward/record.url?scp=84892964718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892964718&partnerID=8YFLogxK

U2 - 10.1053/j.semperi.2013.07.010

DO - 10.1053/j.semperi.2013.07.010

M3 - Article

C2 - 24468571

AN - SCOPUS:84892964718

VL - 38

SP - 56

EP - 62

JO - Seminars in Perinatology

JF - Seminars in Perinatology

SN - 0146-0005

IS - 1

ER -